Taylor & Francis
Neurodegenerative disease management
,  volume 14 ,  issue 6 ,  pages 193-201

Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary

Bruno Brochet 1
, 
Alessandra Solari 2
, 
Jeannette Lechner-Scott 3, 4
, 
Fredrik Piehl 5
, 
Dawn Langdon 6
, 
Raymond Hupperts 7
, 
Krzysztof Selmaj 8, 9
, 
Francesco Patti 10
, 
Luis Brieva 11
, 
Eva Maria Maidal 12
, 
Nektaria Alexandri 13
, 
Andrzej Smyk 13
, 
Axel Nolting 13
, 
Xavier Montalban 14
, 
Eva Kubala Havrdova 15
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
hCenter for Neurology, Lodz, Poland | 
9
 
10
 
11
 
12
 
lMultiple Sclerosis Center, Vienna, Austria | 
13
 
mMerck Healthcare KGaA, Darmstadt, Germany | 
14
 
nepartment of Neurology-Neuroimmunology Centre of Multiple Sclerosis of Catalonia (Cemcat), University Hospital Vall d’Hebron, Barcelona, Spain | 
15
 
Publication type: Journal Article
Publication date: 2024-11-01
Taylor & Francis
scimago Q2
wos Q2
SJR: 0.896
CiteScore: 5.6
Impact factor: 3.4
ISSN: 17582024, 17582032

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Brochet B. et al. Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary // Neurodegenerative disease management. 2024. Vol. 14. No. 6. pp. 193-201.
GOST all authors (up to 50) Copy
Brochet B., Solari A., Lechner-Scott J., Piehl F., Langdon D., Hupperts R., Selmaj K., Patti F., Brieva L., Maidal E. M., Alexandri N., Smyk A., Nolting A., Montalban X., Kubala Havrdova E. Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary // Neurodegenerative disease management. 2024. Vol. 14. No. 6. pp. 193-201.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/17582024.2024.2429970
UR - https://www.tandfonline.com/doi/full/10.1080/17582024.2024.2429970
TI - Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary
T2 - Neurodegenerative disease management
AU - Brochet, Bruno
AU - Solari, Alessandra
AU - Lechner-Scott, Jeannette
AU - Piehl, Fredrik
AU - Langdon, Dawn
AU - Hupperts, Raymond
AU - Selmaj, Krzysztof
AU - Patti, Francesco
AU - Brieva, Luis
AU - Maidal, Eva Maria
AU - Alexandri, Nektaria
AU - Smyk, Andrzej
AU - Nolting, Axel
AU - Montalban, Xavier
AU - Kubala Havrdova, Eva
PY - 2024
DA - 2024/11/01
PB - Taylor & Francis
SP - 193-201
IS - 6
VL - 14
PMID - 39676554
SN - 1758-2024
SN - 1758-2032
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Brochet,
author = {Bruno Brochet and Alessandra Solari and Jeannette Lechner-Scott and Fredrik Piehl and Dawn Langdon and Raymond Hupperts and Krzysztof Selmaj and Francesco Patti and Luis Brieva and Eva Maria Maidal and Nektaria Alexandri and Andrzej Smyk and Axel Nolting and Xavier Montalban and Eva Kubala Havrdova},
title = {Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary},
journal = {Neurodegenerative disease management},
year = {2024},
volume = {14},
publisher = {Taylor & Francis},
month = {nov},
url = {https://www.tandfonline.com/doi/full/10.1080/17582024.2024.2429970},
number = {6},
pages = {193--201},
doi = {10.1080/17582024.2024.2429970}
}
MLA
Cite this
MLA Copy
Brochet, Bruno, et al. “Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary.” Neurodegenerative disease management, vol. 14, no. 6, Nov. 2024, pp. 193-201. https://www.tandfonline.com/doi/full/10.1080/17582024.2024.2429970.